TAS Commercial Concrete Announces a Contract Award of

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
TAS Commercial Concrete Announces a Contract Award of Approximately $14 million

HOUSTON, Aug. 04, 2016 (GLOBE NEWSWIRE) -- Orion Group Holdings, Inc. (NYSE: ORN ) (the "Company") a leading specialty construction company, today announced a contract award of approximately $14 million.

The Company’s commercial concrete segment, TAS Commercial Concrete, was recently awarded a contract from a private sector client in Houston. The project entails concrete construction of a hotel near Houston’s Medical Center and is expected to begin in the 3 rd quarter of 2016 with a duration of approximately 10 months.      

About Orion Group Holdings

Orion Group Holdings, Inc., a leading specialty construction company, provides services both on and off the water in the continental United States, Alaska, Canada and the Caribbean Basin through its heavy civil marine construction segment and its commercial concrete segment. The Company’s heavy civil marine construction segment services includes marine transportation facility construction, marine pipeline construction, marine environmental structures, dredging of waterways, channels and ports, environmental dredging, design, and specialty services. Its commercial concrete segment provides turnkey concrete construction services including pour and finish, dirt work, layout, forming, rebar, and mesh across the light commercial, structural and other associated business areas. The Company is headquartered in Houston, Texas with regional offices throughout its operating areas.

Forward-Looking Statements

The matters discussed in this press release may constitute or include projections or other forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, the provisions of which the Company is availing itself. Certain forward-looking statements can be identified by the use of forward-looking terminology, such as 'believes', 'expects', 'may', 'will', 'could', 'should', 'seeks', 'approximately', 'intends', 'plans', 'estimates', or 'anticipates', or the negative thereof or other comparable terminology, or by discussions of strategy, plans, objectives, intentions, estimates, forecasts, outlook, assumptions, or goals. In particular, statements regarding future operations or results, including those set forth in this press release and any other statement, express or implied, concerning future operating results or the future generation of or ability to generate revenues, income, net income, profit, EBITDA, EBITDA margin, or cash flow, including to service debt, and including any estimates, forecasts or assumptions regarding future revenues or revenue growth, are forward-looking statements. Forward looking statements also include estimated project start date, anticipated revenues, and contract options which may or may not be awarded in the future.  Forward looking statements involve risks, including those associated with the Company's fixed price contracts that impacts profits, unforeseen productivity delays that may alter the final profitability of the contract, cancellation of the contract by the customer for unforeseen reasons, delays or decreases in funding by the customer, levels and predictability of government funding or other governmental budgetary constraints and any potential contract options which may or may not be awarded in the future, and are the sole discretion of award by the customer. Past performance is not necessarily an indicator of future results. In light of these and other uncertainties, the inclusion of forward-looking statements in this press release should not be regarded as a representation by the Company that the Company's plans, estimates, forecasts, goals, intentions, or objectives will be achieved or realized. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof. The Company assumes no obligation to update information contained in this press release whether as a result of new developments or otherwise.

Please refer to the Company’s Annual Report on Form 10-K, filed on March 3, 2016, which is available on its website at www.oriongroupholdingsinc.com or at the SEC’s website at www.sec.gov , for additional and more detailed discussion of risk factors that could cause actual results to differ materially from our current expectations, estimates or forecasts.

Orion Group Holdings Inc. David Griffith, Investor Relations Manager (713) 852-6582

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Grupo Simec 2026 Nine-Month Financial Surge Spells Change

Updated Category News Views 64

Sharp Climb in Net Income Sparks Interest Buckle up, folks. Grupo Simec's nine-month results for 2026 are a mixed bag of surprises and steady flows. Let’s break it down: the net income skyrocketed by a whopping 428% compared to the same period last year—jumping from Ps. 763 million to Ps. 4,028 million. That's a solid leap, and it’s largely due to turning a hefty...

Continue Reading
Cloopen Group's Private Transition: What Investors Should Know

Updated Category News Views 121

Cloopen Steps Away from Public Market Scene Here's a tale simmering on the corporate backburner: Cloopen Group Holding Limited, that cloud juggernaut over in China, has gone all private on us. The ink is drying on their merger with SummerX Holdings Limited, under the overarching umbrella of SpringX Holdings. So, now this communications outfit has slipped out of the public...

Continue Reading
LanguageLine AI App Earns Vizient Technology Kudos

Updated Category News Views 0

Tech Talk: LanguageLine's AI App Gains Important Recognition Diving headfirst into the chaotic world of healthcare, LanguageLine's AI Translation App earned a standout accolade. Just announced, it's snagged the Innovative Technology Designation from Vizient, the heavyweight champ in healthcare performance improvement. On the scene since the end of October, they rolled the...

Continue Reading
Core Lab's Quarterly Grit: Navigating a Turbulent Market

Updated Category News Views 71

Core Lab's Quarter in Review With the kind of resilience that makes a trader's hands shake ever so slightly less over a coffee, Core Laboratories Inc. heads into the fourth quarter of 2026. This isn't your typical Wall Street story, that's for sure. Watching a solid player like Core navigate the bumpy roads of today's volatile market reminds me of a...

Continue Reading
Freddy’s Joins Hershey For a Limited-Time Flavor Fest

Updated Category News Views 95

The Sweet Collaboration We Didn't See Coming Well, folks, here's a tasty twist for you—Freddy's Frozen Custard & Steakburgers is cozying up to The Hershey Company to bring a sugar rush to our mundane lives. Starting Nov. 4, they're rolling out a limited-time series of treats so indulgent you'll want to skip straight to dessert. And if that wasn't enough, they're...

Continue Reading
Bloomberg Law Integrates Docket Data with AI Platform

Updated Category News Views 0

Bloomberg Law's Game-Changer for Legal Pros Here's something that'll make legal eagles perk up on this fine day: Bloomberg Law has rolled out a connector for Claude, marrying court dockets and litigation smarts to AI. Let's face it, the legal world always runs on precision and timing above all. So when an integration like this drops, it ain’t just a memo on the office...

Continue Reading
AppLovin Faces Class Action: AI Growth Claims Under Fire

Updated Category News Views 67

AppLovin's AI Jackpot: A Busted Flush? This year's been a rollercoaster at AppLovin Corporation, and not the fun kind. Let me tell ya, investors bought into a dream—a self-sustaining, profit-churning machine based on AI advertising models. Unfortunately, reality came around like a bad penny, and suddenly, their 'virtuous cycle' feels more like a busted flush....

Continue Reading
Genedata's New ELN Transforms Biopharma R&D Workflows

Updated Category News Views 58

Revolutionizing Research with a New Digital Tool Genedata, the brain behind enterprise software for drug discovery, has thrown a curveball into the world of biopharmaceutical research by launching a pioneering electronic lab notebook (ELN). This isn’t just another software update; it's a complete shift in how R&D workflows are structured and maintained. With an...

Continue Reading
J.H. Strain & Sons' Asset Sale Seals a New Era

Updated Category News Views 59

Texan Legacy Bows Out of the Asphalt Game Here's a fresh chapter in the world of road construction that'll have folks in the industry doing a double-take. Elder Bray & Bankler, a bigwig among corporate law circles, has been guiding this tale. They've shepherded J.H. Strain & Sons through selling off its asphalt manufacturing and construction assets to none other than...

Continue Reading
Motiva's Q3 2026 Results: Strategic Moves Drive Growth

Updated Category News Views 0

Strategic Transactions and Financial Highlights Motiva's third quarter of 2026 shows a company not just coasting but recalibrating its trajectory. Big moves had ripple effects on their financial landscape, most notably their sale of the Airport Platform, concluded for a hefty R$5.2 billion. Their portfolio's trimming isn't just a garage sale but a thought-out step...

Continue Reading

Top 5 Most Recently Viewed Articles

Lilly Flexes Oncology Muscle at 2026 ASCO Meet

Updated Category News Views 19

Lilly's Pipeline Gets the Spotlight With the ASCO conference kicking off in Chicago this year, Eli Lilly (NYSE: LLY) is coming in guns blazing. The company's oncology roster is vast and spread across a variety of tumor types and treatment modalities. This year's presentations are dripping with promise. You got Retevmo leading the charge in a plenary session, joined by...

Continue Reading
David Brenneman Strengthens Antitrust Practice at Latham

Updated Category News Views 212

David Brenneman Joins Latham & Watkins Latham & Watkins LLP is excited to announce a significant addition to their Antitrust & Competition Practice. Renowned antitrust lawyer David Brenneman has joined their Washington, D.C. office as a partner. Brenneman brings considerable expertise in managing the antitrust aspects of various mergers and acquisitions, enhancing the...

Continue Reading
Join the Class Action for Viatris Inc.: Important Updates

Updated Category News Views 419

Understanding the Viatris Class Action Opportunity Attention, investors! If you've purchased securities of Viatris Inc. (NASDAQ: VTRS), this is a critical time for you. The Rosen Law Firm, renowned for advocating investor rights globally, is reaching out to individuals who bought Viatris stocks during an identified time frame. Having knowledge of these events is essential...

Continue Reading
Transformative Health Education: Empowering Future Generations

Updated Category News Views 120

Understanding the Growing Health Crisis A crisis is quietly unfolding in classrooms across the nation: rising rates of preventable chronic illnesses, mental health struggles, and pervasive health illiteracy are significantly impacting the wellness of today's youth. In the face of these alarming statistics, Know Yourself Academy emerges as a beacon of hope, aiming to...

Continue Reading
Free Guide by Pacific Mind Health Eases Anxiety

Updated Category News Views 11

Wrestling with Your Inner Spotlight? Pacific Mind Health Steps In There's a good chance most of us have been there—sweatin' the small stuff like we're the star attraction in the circus of life, convinced everyone else is watching as we trip over our own shoelaces. Well, don't sweat it. Pacific Mind Health has jumped in to lend a hand with some real tools to shake off...

Continue Reading